Sensitivity of the hypothalamic paraventricular nucleus to the locomotor-activating effects of neuromedin U in obesity

Brain Research

Volumn 1169, Issue 1, 2007, Pages 57-68

  Novak, Colleen M ^a   Zhang, Minzhi ^a   Levine, James A ^a  

^a ST MARY S HOSPITAL   (United States)

Author keywords

Diet induced obese (DIO) rats; Energy expenditure; NEAT; Non exercise activity thermogenesis; Obesity; Physical activity

Indexed keywords

NEUROMEDIN U;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CONTROLLED STUDY; DOSE RESPONSE; ENERGY EXPENDITURE; FOOD INTAKE; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; LOCOMOTION; MALE; MICROINJECTION; NONHUMAN; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; THERMOGENESIS;

ANIMALS; BODY WEIGHT; DIETARY FATS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; ENERGY METABOLISM; EXPLORATORY BEHAVIOR; FOOD, FORMULATED; GENETIC PREDISPOSITION TO DISEASE; MALE; MOTOR ACTIVITY; NEUROPEPTIDES; OBESITY; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; THERMOGENESIS;

RATTUS;

EID: 34548514793     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.06.055     Document Type: Article

References (99)

1. Arch J.R., Hislop D., Wang S.J., and Speakman J.R. Some mathematical and technical issues in the measurement and interpretation of open-circuit indirect calorimetry in small animals. Int. J. Obes. (Lond.) 30 (2006) 1322-1331
2. Ballesta J., Carlei F., Bishop A.E., Steel J.H., Gibson S.J., Fahey M., Hennessey R., Domin J., Bloom S.R., and Polak J.M. Occurrence and developmental pattern of neuromedin U-immunoreactive nerves in the gastrointestinal tract and brain of the rat. Neuroscience 25 (1988) 797-816
3. Bamshad M., Song C.K., and Bartness T.J. CNS origins of the sympathetic nervous system outflow to brown adipose tissue. Am. J. Physiol. 276 (1999) R1569-R1578
4. Belke T.W., and Wagner J.P. The reinforcing property and the rewarding aftereffect of wheel running in rats: a combination of two paradigms. Behav. Processes 68 (2005) 165-172
5. Blanchong J.A., McElhinny T.L., Mahoney M.M., and Smale L. Nocturnal and diurnal rhythms in the unstriped Nile rat, Arvicanthis niloticus. J. Biol. Rhythms 14 (1999) 364-377
6. Brady L.S., Smith M.A., Gold P.W., and Herkenham M. Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats. Neuroendocrinology 52 (1990) 441-447
7. Brown D.W., Brown D.R., Heath G.W., Balluz L., Giles W.H., Ford E.S., and Mokdad A.H. Associations between physical activity dose and health-related quality of life. Med. Sci. Sports Exerc. 36 (2004) 890-896
8. Castaneda T.R., Jurgens H., Wiedmer P., Pfluger P., Diano S., Horvath T.L., Tang-Christensen M., and Tschop M.H. Obesity and the neuroendocrine control of energy homeostasis: the role of spontaneous locomotor activity. J. Nutr. 135 (2005) 1314-1319
9. Chang G.Q., Karatayev O., Davydova Z., and Leibowitz S.F. Circulating triglycerides impact on orexigenic peptides and neuronal activity in hypothalamus. Endocrinology 145 (2004) 3904-3912
10. Chappell P.B., Smith M.A., Kilts C.D., Bissette G., Ritchie J., Anderson C., and Nemeroff C.B. Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J. Neurosci. 6 (1986) 2908-2914
11. Clegg D.J., Benoit S.C., Reed J.A., Woods S.C., Dunn-Meynell A., and Levin B.E. Reduced anorexic effects of insulin in obesity-prone rats fed a moderate-fat diet. Am. J. Physiol., Regul. Integr. Comp. Physiol. 288 (2005) R981-R986
12. Dauncey M.J. Activity and energy expenditure. Can. J. Physiol. Pharm. 68 (1990) 17-27
13. Dixon D.P., Ackert A.M., and Eckel L.A. Development of, and recovery from, activity-based anorexia in female rats. Physiol. Behav. 80 (2003) 273-279
14. Donahoo W.T., Levine J.A., and Melanson E.L. Variability in energy expenditure and its components. Curr. Opin. Clin. Nutr. Metab. Care 7 (2004) 599-605
15. Flegal K.M., Carroll M.D., Ogden C.L., and Johnson C.L. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288 (2002) 1723-1727
16. Funahashi H., Hori T., Shimoda Y., Mizushima H., Ryushi T., Katoh S., and Shioda S. Morphological evidence for neural interactions between leptin and orexin in the hypothalamus. Regulatory Pept. 92 (2000) 31-35
17. Gartlon J., Szekeres P., Pullen M., Sarau H.M., Aiyar N., Shabon U., Michalovich D., Steplewski K., Ellis C., Elshourbagy N., Duxon M., Ashmeade T.E., Harrison D.C., Murdock P., Wilson S., Ennaceur A., Atkins A., Heidbreder C., Hagan J.J., Hunter A.J., and Jones D.N. Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in rats. Psychopharmacology (Berl.) 177 (2004) 1-14
18. Giammattei J., Blix G., Marshak H.H., Wollitzer A.O., and Pettitt D.J. Television watching and soft drink consumption: associations with obesity in 11- to 13-year-old schoolchildren. Arch. Pediatr. Adolesc. Med. 157 (2003) 882-886
19. Graham E.S., Turnbull Y., Fotheringham P., Nilaweera K., Mercer J.G., Morgan P.J., and Barrett P. Neuromedin U and Neuromedin U receptor-2 expression in the mouse and rat hypothalamus: effects of nutritional status. J. Neurochem. 87 (2003) 1165-1173
20. Green C.B., Douris N., Kojima S., Strayer C.A., Fogerty J., Lourim D., Keller S.R., and Besharse J.C. From the cover: loss of Nocturnin, a circadian deadenylase, confers resistance to hepatic steatosis and diet-induced obesity. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 9888-9893
21. Guan X.M., Yu H., Jiang Q., Van Der Ploeg L.H., and Liu Q. Distribution of neuromedin U receptor subtype 2 mRNA in the rat brain. Brain Res. Gene Expr. Patterns 1 (2001) 1-4
22. Hanada R., Nakazato M., Murakami N., Sakihara S., Yoshimatsu H., Toshinai K., Hanada T., Suda T., Kangawa K., Matsukura S., and Sakata T. A role for neuromedin U in stress response. Biochem. Biophys. Res. Commun. 289 (2001) 225-228
23. Hanada T., Date Y., Shimbara T., Sakihara S., Murakami N., Hayashi Y., Kanai Y., Suda T., Kangawa K., and Nakazato M. Central actions of neuromedin U via corticotropin-releasing hormone. Biochem. Biophys. Res. Commun. 311 (2003) 954-958
24. Hanada R., Teranishi H., Pearson J.T., Kurokawa M., Hosoda H., Fukushima N., Fukue Y., Serino R., Fujihara H., Ueta Y., Ikawa M., Okabe M., Murakami N., Shirai M., Yoshimatsu H., Kangawa K., and Kojima M. Neuromedin U has a novel anorexigenic effect independent of the leptin signaling pathway. Nat. Med. 10 (2004) 1067-1073
25. Hainerova I., Torekov S.S., Ek J., Finkova M., Borch-Johnsen K., Jorgensen T., Madsen O.D., Lebl J., Hansen T., and Pedersen O. Association between neuromedin U gene variants and overweight and obesity. J. Clin. Endocrinol. Metab. 91 (2006) 5057-5063
26. Harris R.B. Growth measurements in Sprague-Dawley rats fed diets of very low fat concentration. J. Nutr. 121 (1991) 1075-1080
27. Heini A.F., and Weinsier R.L. Divergent trends in obesity and fat intake patterns: the American paradox. Am. J. Med. 102 (1997) 259-264
28. Hermes M.L., Buijs R.M., and Renaud L.P. Electrophysiology of suprachiasmatic nucleus projections to hypothalamic paraventricular nucleus neurons. Prog. Brain Res. 111 (1996) 241-252
29. Howard A.D., Wang R., Pong S.S., Mellin T.N., Strack A., Guan X.M., Zeng Z., Williams Jr. D.L., Feighner S.D., Nunes C.N., Murphy B., Stair J.N., Yu H., Jiang Q., Clements M.K., Tan C.P., McKee K.K., Hreniuk D.L., McDonald T.P., Lynch K.R., Evans J.F., Austin C.P., Caskey C.T., Van der Ploeg L.H., and Liu Q. Identification of receptors for neuromedin U and its role in feeding. Nature 406 (2000) 70-74
30. Hu F.B., Li T.Y., Colditz G.A., Willett W.C., and Manson J.E. Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA 289 (2003) 1785-1791
31. Hu F.B., Willett W.C., Li T., Stampfer M.J., Colditz G.A., and Manson J.E. Adiposity as compared with physical activity in predicting mortality among women. Obstet. Gynecol. Surv. 60 (2005) 311-312
32. Ichikawa M., Miyasaka K., Fujita Y., Shimazoe T., and Funakoshi A. Disappearance of diurnal rhythm of energy expenditure in genetically diabetic obese rats. Jpn. J. Physiol. 48 (1998) 211-214
33. Ida T., Mori K., Miyazato M., Egi Y., Abe S., Nakahara K., Nishihara M., Kangawa K., and Murakami N. Neuromedin s is a novel anorexigenic hormone. Endocrinology 146 (2005) 4217-4223
34. Ivanov T.R., Lawrence C.B., Stanley P.J., and Luckman S.M. Evaluation of neuromedin U actions in energy homeostasis and pituitary function. Endocrinology 143 (2002) 3813-3821
35. Ivanov T.R., Le Rouzic P., Stanley P.J., Ling W.Y., Parello R., and Luckman S.M. Neuromedin U neurones in the rat nucleus of the tractus solitarius are catecholaminergic and respond to peripheral cholecystokinin. J. Neuroendocrinol. 16 (2004) 612-619
36. James P.T., Leach R., Kalamara E., and Shayeghi M. The worldwide obesity epidemic. Obes. Res. 9 Suppl 4 (2001) 228S-233S
37. Jethwa P.H., Small C.J., Smith K.L., Seth A., Darch S.J., Abbott C.R., Murphy K.G., Todd J.F., Ghatei M.A., and Bloom S.R. Neuromedin U has a physiological role in the regulation of food intake and partially mediates the effects of leptin. Am. J. Physiol: Endocrinol. Metab. 289 (2005) E301-E305
38. Kas M.J., and Edgar D.M. A nonphotic stimulus inverts the diurnal-nocturnal phase preference in Octodon degus. J. Neurosci. 19 (1999) 328-333
39. Kiwaki K., Kotz C.M., Wang C., Lanningham-Foster L., and Levine J.A. Orexin A (hypocretin 1) injected into hypothalamic paraventricular nucleus and spontaneous physical activity in rats. Am. J. Physiol: Endocrinol. Metab. 286 (2004) E551-E559
40. Kotz C.M. Integration of feeding and spontaneous physical activity: role for orexin. Physiol. Behav. 88 (2006) 294-301
41. Kotz C.M., Briggs J.E., Grace M.K., Levine A.S., and Billington C.J. Divergence of the feeding and thermogenic pathways influenced by NPY in the hypothalamic PVN of the rat. Am. J. Physiol. 275 (1998) R471-R477
42. Kotz C.M., Briggs J.E., Pomonis J.D., Grace M.K., Levine A.S., and Billington C.J. Neural site of leptin influence on neuropeptide Y signaling pathways altering feeding and uncoupling protein. Am. J. Physiol. 275 (1998) R478-R484
43. Kotz C.M., Wang C., Levine A.S., and Billington C.J. Urocortin in the hypothalamic PVN increases leptin and affects uncoupling proteins-1 and -3 in rats. Am. J. Physiol., Regul. Integr. Comp. Physiol. 282 (2002) R546-R551
44. Kowalski T.J., Spar B.D., Markowitz L., Maguire M., Golovko A., Yang S., Farley C., Cook J.A., Tetzloff G., Hoos L., Del Vecchio R.A., Kazdoba T.M., McCool M.F., Hwa J.J., Hyde L.A., Davis H., Vassileva G., Hedrick J.A., and Gustafson E.L. Transgenic overexpression of neuromedin U promotes leanness and hypophagia in mice. J. Endocrinol. 185 (2005) 151-164
45. Kristensen P., Judge M.E., Thim L., Ribel U., Christjansen K.N., Wulff B.S., Clausen J.T., Jensen P.B., Madsen O.D., Vrang N., Larsen P.J., and Hastrup S. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 393 (1998) 72-76
46. Lam T.K., Schwartz G.J., and Rossetti L. Hypothalamic sensing of fatty acids. Nat. Neurosci. 8 (2005) 579-584
47. Leak R.K., and Moore R.Y. Topographic organization of suprachiasmatic nucleus projection neurons. J. Comp. Neurol. 433 (2001) 312-334
48. Leibowitz S.F., and Wortley K.E. Hypothalamic control of energy balance: different peptides, different functions. Peptides 25 (2004) 473-504
49. Levin B.E. Spontaneous motor activity during the development and maintenance of diet-induced obesity in the rat. Physiol. Behav. 50 (1991) 573-581
50. Levin B.E. Reduced paraventricular nucleus norepinephrine responsiveness in obesity-prone rats. Am. J. Physiol. 270 (1996) R456-R461
51. Levin B.E., and Dunn-Meynell A.A. Defense of body weight against chronic caloric restriction in obesity-prone and -resistant rats. Am. J. Physiol., Regul. Integr. Comp. Physiol. 278 (2000) R231-R237
52. Levin B.E., and Dunn-Meynell A.A. Reduced central leptin sensitivity in rats with diet-induced obesity. Am. J. Physiol., Regul. Integr. Comp. Physiol. 283 (2002) R941-R948
53. Levin B.E., Triscari J., and Sullivan A.C. Metabolic features of diet-induced obesity without hyperphagia in young rats. Am. J. Physiol. 251 (1986) R433-R440
54. Levin B.E., Hogan S., and Sullivan A.C. Initiation and perpetuation of obesity and obesity resistance in rats. Am. J. Physiol. 256 (1989) R766-R771
55. Levin B.E., Dunn-Meynell A.A., Balkan B., and Keesey R.E. Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats. Am. J. Physiol. 273 (1997) R725-R730
56. Levine J.A., Eberhardt N.L., and Jensen M.D. Role of nonexercise activity thermogenesis in resistance to fat gain in humans. Science 283 (1999) 212-214
57. Levin B.E., Richard D., Michel C., and Servatius R. Differential stress responsivity in diet-induced obese and resistant rats. Am. J. Physiol., Regul. Integr. Comp. Physiol. 279 (2000) R1357-R1364
58. Levine J., Melanson E.L., Westerterp K.R., and Hill J.O. Measurement of the components of nonexercise activity thermogenesis. Am. J. Physiol. Endocrinol. Metab. 281 (2001) E670-E675
59. Levin B.E., Dunn-Meynell A.A., McMinn J.E., Alperovich M., Cunningham-Bussel A., and Chua Jr. S.C. A new obesity-prone, glucose-intolerant rat strain (F.DIO). Am. J. Physiol., Regul. Integr. Comp. Physiol. 285 (2003) R1184-R1191
60. Levin B.E., Dunn-Meynell A.A., and Banks W.A. Obesity-prone rats have normal blood-brain barrier transport but defective central leptin signaling before obesity onset. Am. J. Physiol., Regul. Integr. Comp. Physiol. 286 (2004) R143-R150
61. Levin B.E., Magnan C., Migrenne S., Chua Jr. S.C., and Dunn-Meynell A.A. F-DIO obesity-prone rat is insulin resistant before obesity onset. Am. J. Physiol., Regul. Integr. Comp. Physiol. 289 (2005) R704-R711
62. Levine J.A., Lanningham-Foster L.M., McCrady S.K., Krizan A.C., Olson L.R., Kane P.H., Jensen M.D., and Clark M.M. Interindividual variation in posture allocation: possible role in human obesity. Science 307 (2005) 584-586
63. Lohman R.J., Liu L., Morris M., and O'Brien T.J. Validation of a method for localised microinjection of drugs into thalamic subregions in rats for epilepsy pharmacological studies. J. Neurosci. Methods 146 (2005) 191-197
64. Lopez M., Seoane L., Garcia M.C., Lago F., Casanueva F.F., Senaris R., and Dieguez C. Leptin regulation of prepro-orexin and orexin receptor mRNA levels in the hypothalamus. Biochem. Biophys. Res. Commun. 269 (2000) 41-45
65. Michel C., Dunn-Meynell A., and Levin B.E. Reduced brain CRH and GR mRNA expression precedes obesity in juvenile rats bred for diet-induced obesity. Behav. Brain Res. 154 (2004) 511-517
66. Miyasaka K., Ichikawa M., Momose K., Araki A., Kobayashi M., Ichimaru Y., and Funakoshi A. Physiological and pathological age-associated changes in diurnal rhythm of energy expenditure in rats. Arch. Gerontol. Geriatr. 39 (2004) 83-91
67. Mori K., Miyazato M., Ida T., Murakami N., Serino R., Ueta Y., Kojima M., and Kangawa K. Identification of neuromedin S and its possible role in the mammalian circadian oscillator system. EMBO J. 24 (2005) 325-335
68. Nakahara K., Hanada R., Murakami N., Teranishi H., Ohgusu H., Fukushima N., Moriyama M., Ida T., Kangawa K., and Kojima M. The gut-brain peptide neuromedin U is involved in the mammalian circadian oscillator system. Biochem. Biophys. Res. Commun. 318 (2004) 156-161
69. Nakazato M., Hanada R., Murakami N., Date Y., Mondal M.S., Kojima M., Yoshimatsu H., Kangawa K., and Matsukura S. Central effects of neuromedin U in the regulation of energy homeostasis. Biochem. Biophys. Res. Commun. 277 (2000) 191-194
70. Niimi M., Murao K., and Taminato T. Central administration of neuromedin U activates neurons in ventrobasal hypothalamus and brainstem. Endocrine 16 (2001) 201-206
71. Novak C.M., Jiang X., Wang C., Teske J.A., Kotz C.M., and Levine J.A. Caloric restriction and physical activity in zebrafish (Danio rerio). Neurosci. Lett. 383 (2005) 99-104
72. Novak C.M., Kotz C.M., and Levine J.A. Central orexin sensitivity, physical activity, and obesity in diet-induced obese and diet-resistant rats. Am. J. Physiol: Endocrinol. Metab. 290 (2006) E396-E403
73. Novak C.M., Zhang M., and Levine J.A. Neuromedin U in the paraventricular and arcuate hypothalamic nuclei increases non-exercise activity thermogenesis. J. Neuroendocrinol. 18 (2006) 594-601
74. Ogden C.L., Fryar C.D., Carroll M.D., and Flegal K.M. Mean body weight, height, and body mass index, United States 1960-2002. Adv. Data (2004) 1-17
75. Ozaki Y., Onaka T., Nakazato M., Saito J., Kanemoto K., Matsumoto T., and Ueta Y. Centrally administered neuromedin U activates neurosecretion and induction of c-fos messenger ribonucleic acid in the paraventricular and supraoptic nuclei of rat. Endocrinology 143 (2002) 4320-4329
76. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 5 edn. (2005), Elsevier Academic Press
77. Qiu D.L., Chu C.P., Shirasaka T., Nabekura T., Kunitake T., Kato K., Nakazato M., Katoh T., and Kannan H. Neuromedin U depolarizes rat hypothalamic paraventricular nucleus neurons in vitro by enhancing IH channel activity. J. Neurophysiol. 90 (2003) 843-850
78. Qiu D.L., Chu C.P., Tsukino H., Shirasaka T., Nakao H., Kato K., Kunitake T., Katoh T., and Kannan H. Neuromedin U receptor-2 mRNA and HCN channels mRNA expression in NMU-sensitive neurons in rat hypothalamic paraventricular nucleus. Neurosci. Lett. 374 (2005) 69-72
79. Raddatz R., Wilson A.E., Artymyshyn R., Bonini J.A., Borowsky B., Boteju L.W., Zhou S., Kouranova E.V., Nagorny R., Guevarra M.S., Dai M., Lerman G.S., Vaysse P.J., Branchek T.A., Gerald C., Forray C., and Adham N. Identification and characterization of two neuromedin U receptors differentially expressed in peripheral tissues and the central nervous system. J. Biol. Chem. 275 (2000) 32452-32459
80. Redlin U., and Mrosovsky N. Nocturnal activity in a diurnal rodent (Arvicanthis niloticus): the importance of masking. J. Biol. Rhythms 19 (2004) 58-67
81. Rissanen A.M., Heliovaara M., Knekt P., Reunanen A., and Aromaa A. Determinants of weight gain and overweight in adult Finns. Eur. J. Clin. Nutr. 45 (1991) 419-430
82. Shan L., Qiao X., Crona J.H., Behan J., Wang S., Laz T., Bayne M., Gustafson E.L., Monsma Jr. F.J., and Hedrick J.A. Identification of a novel neuromedin U receptor subtype expressed in the central nervous system. J. Biol. Chem. 275 (2000) 39482-39486
83. Sherwin C.M. Voluntary wheel running: a review and novel interpretation. Anim. Behav. 56 (1998) 11-27
84. Steel J.H., Van Noorden S., Ballesta J., Gibson S.J., Ghatei M.A., Burrin J., Leonhardt U., Domin J., Bloom S.R., and Polak J.M. Localization of 7B2, neuromedin B, and neuromedin U in specific cell types of rat, mouse, and human pituitary, in rat hypothalamus, and in 30 human pituitary and extrapituitary tumors. Endocrinology 122 (1988) 270-282
85. Sutton R.E., Koob G.F., Le Moal M., Rivier J., and Vale W. Corticotropin releasing factor produces behavioural activation in rats. Nature 297 (1982) 331-333
86. Tang-Christensen M., Vrang N., Ortmann S., Bidlingmaier M., Horvath T.L., and Tschop M. Central administration of ghrelin and agouti-related protein (83-132) increases food intake and decreases spontaneous locomotor activity in rats. Endocrinology 145 (2004) 4645-4652
87. Teske J.A., Levine A.S., Kuskowski M., Levine J.A., and Kotz C.M. Elevated hypothalamic orexin signaling, sensitivity to orexin A and spontaneous physical activity in obesity resistant rats. Am. J. Physiol., Regul. Integr. Comp. Physiol. (2006)
88. Thompson E.L., Murphy K.G., Todd J.F., Martin N.M., Small C.J., Ghatei M.A., and Bloom S.R. Chronic administration of NMU into the paraventricular nucleus stimulates the HPA axis but does not influence food intake or body weight. Biochem. Biophys. Res. Commun. 323 (2004) 65-71
89. Tkacs N.C., and Levin B.E. Obesity-prone rats have preexisting defects in their counterregulatory response to insulin-induced hypoglycemia. Am. J. Physiol., Regul. Integr. Comp. Physiol. 287 (2004) R1110-R1115
90. Turek F.W., Joshu C., Kohsaka A., Lin E., Ivanova G., McDearmon E., Laposky A., Losee-Olson S., Easton A., Jensen D.R., Eckel R.H., Takahashi J.S., and Bass J. Obesity and metabolic syndrome in circadian Clock mutant mice. Science 308 (2005) 1043-1045
91. van Baak M.A., van Mil E., Astrup A.V., Finer N., Van Gaal L.F., Hilsted J., Kopelman P.G., Rossner S., James W.P., and Saris W.H. Leisure-time activity is an important determinant of long-term weight maintenance after weight loss in the Sibutramine Trial on Obesity Reduction and Maintenance (STORM trial). Am. J. Clin. Nutr. 78 (2003) 209-214
92. Wen L.M., Orr N., Millett C., and Rissel C. Driving to work and overweight and obesity: findings from the 2003 New South Wales Health Survey, Australia. Int. J. Obes. (Lond.) 30 (2006) 782-786
93. Weinsier R.L., Nelson K.M., Hensrud D.D., Darnell B.E., Hunter G.R., and Schutz Y. Metabolic predictors of obesity. Contribution of resting energy expenditure, thermic effect of food, and fuel utilization to four-year weight gain of post-obese and never-obese women. J. Clin. Invest. 95 (1995) 980-985
94. Weinsier R.L., Hunter G.R., Heini A.F., Goran M.I., and Sell S.M. The etiology of obesity: relative contribution of metabolic factors, diet, and physical activity. Am. J. Med. 105 (1998) 145-150
95. Wortley K.E., Chang G.Q., Davydova Z., and Leibowitz S.F. Peptides that regulate food intake: orexin gene expression is increased during states of hypertriglyceridemia. Am. J. Physiol., Regul. Integr. Comp. Physiol. 284 (2003) R1454-R1465
96. Wren A.M., Small C.J., Abbott C.R., Jethwa P.H., Kennedy A.R., Murphy K.G., Stanley S.A., Zollner A.N., Ghatei M.A., and Bloom S.R. Hypothalamic actions of neuromedin U. Endocrinology 143 (2002) 4227-4234
97. Wyatt H.R., Peters J.C., Reed G.W., Barry M., and Hill J.O. A Colorado statewide survey of walking and its relation to excessive weight. Med. Sci. Sports Exerc. 37 (2005) 724-730
98. Yokota M., Ozaki Y., Sakamoto F., Yamada S., Saito J., Fujihara H., and Ueta Y. Fos expression in CRF-containing neurons in the rat paraventricular nucleus after central administration of neuromedin U. Stress 7 (2004) 109-112
99. Zhu Y., Yamanaka A., Kunii K., Tsujino N., Goto K., and Sakurai T. Orexin-mediated feeding behavior involves both leptin-sensitive and -insensitive pathways. Physiol. Behav. 77 (2002) 251-257